Clinical Trial Update: Exploring Whether Disease-free Intervals Can Guide Endocrine Combined Targeted Therapy for ER+/HER2+ Advanced Breast Cancer (T-sunflower) [Phase 2]

View source ↗

Summary

A Phase 2 trial investigating whether disease-free intervals can guide endocrine combined targeted therapy for ER+/HER2+ metastatic breast cancer; current statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Fudan University | Conditions: Metastatic Breast Cancer | Phase 2 | Status: UNKNOWN